At last, we confirmed that cisplatin induces oxPAPC release, and thus promotes MDSCs infiltration to tumour via activating the MCP‐1/CCL2 and LTB4/LTB4R axis, potentially boosting tumour growth. The gene discussed is CCL2; the disease is neoplasm.